{
    "eid": "2-s2.0-84969601864",
    "title": "Treatment outcomes of gestational trophoblastic neoplasia in king chulalongkorn memorial hospital over two decades",
    "cover-date": "2016-06-01",
    "subject-areas": [
        {
            "$": "Reproductive Medicine",
            "@code": "2743"
        },
        {
            "$": "Obstetrics and Gynecology",
            "@code": "2729"
        }
    ],
    "keywords": [
        "Antineoplastic combined chemotherapy protocols",
        "Antineoplastic combined chemotherapy regimens",
        "Cancer chemotherapy protocols",
        "Chemotherapy",
        "Choriocarcinoma",
        "Epidemiology",
        "Gestational trophoblastic disease",
        "Gestational trophoblastic neoplasia",
        "Hydatidiform mole",
        "Incidence",
        "Uterine cancer"
    ],
    "authors": [
        "Ruangsak Lertkhachonsuk"
    ],
    "citedby-count": 4,
    "ref-count": 23,
    "ref-list": [
        "Chula Med J",
        "Treatment of metastatic trophoblastic disease: Good and poor prognosis",
        "Gestational trophoblastic disease: Treatment results at the brewer trophoblastic disease center",
        "Low-risk persistent gestational trophoblastic disease: Outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000",
        "Gestational trophoblastic disease",
        "Gestational trophoblastic neoplasia management: An update",
        "Gestational trophoblastic disease: ESMO clinical practice guidelines for diagnosis, treatment and follow-up",
        "Recent advances in gestational trophoblastic disease",
        "The changing clinical presentation of complete molar pregnancy",
        "Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: Does early diagnosis alter risk for gestational trophoblastic neoplasia?",
        "The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia",
        "Gestational trophoblastic neoplasia, FIGO 2000 staging and classification",
        "Under-registration of gestational trophoblastic disease in the Swedish Cancer Registry",
        "EPIDEMIOLOGICAL ASPECTS OF HYDATIDIFORM MOLE IN THE REPUBLIC OF PARAGUAY (SOUTH AMERICA)",
        "Hydatidiform Mole, Invasive Mole and Choriocarcinoma in Sweden 1958\u20131965",
        "Incidence of gestational trophoblastic disease by regional registration in Japan",
        "Gestational trophoblastic disease epidemiology and trends",
        "Gestational trophoblastic neoplasia, FIGO 2000 staging and classification",
        "First-line chemotherapy in low-risk gestational trophoblastic neoplasia",
        "Management of brain metastases in patients with high-risk gestational trophoblastic tumors",
        "Serum human chorionic gonadotropin regression pattern in persistent trophoblastic disease during chemotherapy",
        "Actinomycin D versus methotrexate-folinic acid as",
        "Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "Chulalongkorn University",
        "affiliation-country": "Thailand"
    },
    "funding": []
}